{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:36Z","timestamp":1787003856564,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01133-w","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T09:03:18Z","timestamp":1758531798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal evaluation of serum cholinesterase benefits prognosis surveillance of common types of human cancer"],"prefix":"10.1038","volume":"5","author":[{"given":"Chunxia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-9316","authenticated-orcid":false,"given":"Bingbing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-1891","authenticated-orcid":false,"given":"Dingyun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-2588","authenticated-orcid":false,"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-4443","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"1133_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1133_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cac2.12393","volume":"43","author":"R Feng","year":"2023","unstructured":"Feng, R. et al. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun. 43, 75\u201386 (2023).","journal-title":"Cancer Commun."},{"key":"1133_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2011.121","volume":"8","author":"NB La Thangue","year":"2011","unstructured":"La Thangue, N. B. & Kerr, D. J. Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat. Rev. Clin. Oncol. 8, 587\u2013596 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1133_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103577","volume":"72","author":"DJ Kerr","year":"2021","unstructured":"Kerr, D. J. & Yang, L. Personalising cancer medicine with prognostic markers. EBioMedicine 72, 103577 (2021).","journal-title":"EBioMedicine"},{"key":"1133_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.ejca.2007.03.021","volume":"43","author":"MJ Duffy","year":"2007","unstructured":"Duffy, M. J. et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer 43, 1348\u20131360 (2007).","journal-title":"Eur. J. Cancer"},{"key":"1133_CR6","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ijc.28384","volume":"134","author":"MJ Duffy","year":"2014","unstructured":"Duffy, M. J. et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int. J. Cancer 134, 2513\u20132522 (2014).","journal-title":"Int. J. Cancer"},{"key":"1133_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/gut.1.4.294","volume":"1","author":"W Burnett","year":"1960","unstructured":"Burnett, W. An assessment of the value of serum cholinesterase as a liver function test and in the diagnosis of jaundice. Gut 1, 294\u2013302 (1960).","journal-title":"Gut"},{"key":"1133_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2013","unstructured":"Santarpia, L., Grandone, I., Contaldo, F. & Pasanisi, F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J. Cachexia Sarcopenia Muscle 4, 31\u201339 (2013).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1133_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00345-023-04449-1","volume":"41","author":"M von Deimling","year":"2023","unstructured":"von Deimling, M. et al. Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma. World J. Urol. 41, 1861\u20131868 (2023).","journal-title":"World J. Urol."},{"key":"1133_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10147-015-0880-x","volume":"21","author":"T Koie","year":"2016","unstructured":"Koie, T. et al. Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy. Int. J. Clin. Oncol. 21, 379\u2013383 (2016).","journal-title":"Int. J. Clin. Oncol."},{"key":"1133_CR11","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1016\/j.clgc.2018.07.002","volume":"16","author":"S Kimura","year":"2018","unstructured":"Kimura, S. et al. Prognostic value of serum cholinesterase in non-muscle-invasive bladder cancer. Clin. Genitourin. Cancer 16, e1123\u2013e1132 (2018).","journal-title":"Clin. Genitourin. Cancer"},{"key":"1133_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaoncol.2017.4420","volume":"4","author":"T Konishi","year":"2018","unstructured":"Konishi, T. et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncol. 4, 309\u2013315 (2018).","journal-title":"JAMA Oncol."},{"key":"1133_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103706","volume":"74","author":"C Li","year":"2021","unstructured":"Li, C. et al. Trajectories of perioperative serum tumor markers and colorectal cancer outcomes: a retrospective, multicenter longitudinal cohort study. EBioMedicine 74, 103706 (2021).","journal-title":"EBioMedicine"},{"key":"1133_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.scib.2023.07.039","volume":"68","author":"C Li","year":"2023","unstructured":"Li, C. et al. Perioperative changing patterns and longitudinal trajectories of CA242 with colorectal cancer prognosis: a retrospective longitudinal cohort study. Sci. Bull. 68, 1875\u20131879 (2023).","journal-title":"Sci. Bull."},{"key":"1133_CR15","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Non-Small Cell Lung Cancer. Version 8.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf (2025)."},{"key":"1133_CR16","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Colon Cancer. Version 4.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf (2025)."},{"key":"1133_CR17","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Rectal Cancer. Version 3.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf (2025)."},{"key":"1133_CR18","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Gastric Cancer. Version 3.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf (2025)."},{"key":"1133_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman, S. & Simon, R. Flexible regression models with cubic splines. Stat. Med. 8, 551\u2013561 (1989).","journal-title":"Stat. Med."},{"key":"1133_CR20","doi-asserted-by":"crossref","unstructured":"Harrell, F. E. General Aspects of Fitting Regression Models. In Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. 11\u201340 (Springer, 2001).","DOI":"10.1007\/978-1-4757-3462-1_2"},{"key":"1133_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.293","volume":"11","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Trajectories of perioperative serum carcinoembryonic antigen and colorectal cancer outcome: a retrospective, multicenter longitudinal cohort study. Clin. Transl. Med. 11, e293 (2021).","journal-title":"Clin. Transl. Med."},{"key":"1133_CR22","doi-asserted-by":"publisher","first-page":"e020683","DOI":"10.1136\/bmjopen-2017-020683","volume":"8","author":"H Lennon","year":"2018","unstructured":"Lennon, H. et al. Framework to construct and interpret latent class trajectory modelling. BMJ Open 8, e020683 (2018).","journal-title":"BMJ Open"},{"key":"1133_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09212-0","volume":"22","author":"H Ran","year":"2022","unstructured":"Ran, H. et al. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer. BMC Cancer 22, 93 (2022).","journal-title":"BMC Cancer"},{"key":"1133_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00384-022-04119-5","volume":"37","author":"Y Takano","year":"2022","unstructured":"Takano, Y. et al. The impact of low serum cholinesterase levels on survival in patients with colorectal cancer. Int. J. Colorectal Dis. 37, 869\u2013877 (2022).","journal-title":"Int. J. Colorectal Dis."},{"key":"1133_CR25","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1016\/S0261-5614(19)32367-2","volume":"38","author":"MON-PO534","year":"2019","unstructured":"MON-PO534 Clinical impact of preoperative serum cholinesterase in gastric cancer. Clin. Nutr. 38, S256 (2019).","journal-title":"Clin. Nutr."},{"key":"1133_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s10388-019-00681-0","volume":"16","author":"K Ishii","year":"2019","unstructured":"Ishii, K., Tsubosa, Y., Niihara, M., Akai, T. & Soneda, W. Changes in the nutritional status of elderly patients after esophagectomy. Esophagus 16, 408\u2013412 (2019).","journal-title":"Esophagus"},{"key":"1133_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.580800","volume":"27","author":"Y Bi","year":"2021","unstructured":"Bi, Y. et al. Cholinesterase is associated with prognosis and response to chemotherapy in advanced gastric cancer. Pathol. Oncol. Res. 27, 580800 (2021).","journal-title":"Pathol. Oncol. Res."},{"key":"1133_CR28","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.4103\/jcrt.JCRT_207_16","volume":"16","author":"SG Jaiswal","year":"2020","unstructured":"Jaiswal, S. G. & Jaiswal, G. R. Butyrylcholinesterase: an economical marker of disease activity in oral squamous cell carcinoma before and after therapy. J. Cancer Res. Ther. 16, S39\u2013S42 (2020).","journal-title":"J. Cancer Res. Ther."},{"key":"1133_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.21873\/invivo.11466","volume":"33","author":"H Kawahara","year":"2019","unstructured":"Kawahara, H. et al. Anthropometric assessment after proctocolectomy due to ulcerative colitis. Vivo 33, 239\u2013243 (2019).","journal-title":"Vivo"},{"key":"1133_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/0973-1482.39601","volume":"4","author":"A Chougule","year":"2008","unstructured":"Chougule, A., Hussain, S. & Agarwal, D. P. Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy. J. Cancer Res. Ther. 4, 21\u201325 (2008).","journal-title":"J. Cancer Res. Ther."},{"key":"1133_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MPH.0000000000000828","volume":"39","author":"DW Coulter","year":"2017","unstructured":"Coulter, D. W. et al. Butyrylcholinesterase as a blood biomarker in neuroblastoma. J. Pediatr. Hematol. Oncol. 39, 272\u2013281 (2017).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"1133_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cbi.2016.04.014","volume":"259","author":"FJ Campoy","year":"2016","unstructured":"Campoy, F. J. et al. Cholinergic system and cell proliferation. Chem. Biol. Interact. 259, 257\u2013265 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"1133_CR33","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0024-3205(03)00078-X","volume":"72","author":"P Song","year":"2003","unstructured":"Song, P. et al. Synthesis of acetylcholine by lung cancer. Life Sci. 72, 2159\u20132168 (2003).","journal-title":"Life Sci."},{"key":"1133_CR34","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.chest.2020.03.014","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang, X. & Kattan, M. W. Cohort studies: design, analysis, and reporting. Chest 158, S72\u2013S78 (2020).","journal-title":"Chest"},{"key":"1133_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/hep.1840080216","volume":"8","author":"H Kawasaki","year":"1988","unstructured":"Kawasaki, H., Hori, T., Nakajima, M. & Takeshita, K. Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology 8, 286\u2013289 (1988).","journal-title":"Hepatology"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01133-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T09:03:24Z","timestamp":1758531804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01133-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"391"}}